NGF and early-onset autosomal dominant Alzheimer disease: The intra-brain administration of NGF was shown to have beneficial effects in patients affected by Parkinson’s and Alzheimer’s diseases (A), while the intraocular injection of NGF in an animal model of the optic nerve section was shown to prevent retinal ganglion cell degeneration [12].